Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output

This publication has 25 references indexed in Scilit:

• Dopexamine Hydrochloride: A Novel Dopamine Receptor Agonist for the Acute Treatment of Low Cardiac Output States
  Cardiovascular Drug Reviews, 1989
• Potentiation by Dopexamine of the Cardiac Responses to Circulating and Neuronally Released Norepinephrine
  Journal of Cardiovascular Pharmacology, 1989
• An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride)
  The American Journal of Cardiology, 1988
• Review: The Pharmacology of Dobutamine
  The Lancet Healthy Longevity, 1987
• Inhibition of Uptake₁ by dopexamine hydrochloride in vitro)
  British Journal of Pharmacology, 1987
• New Inotropic Drugs for Heart Failure
  JAMA, 1987
• Dopexamine: a novel agonist at peripheral dopamine receptors and β₂‐adrenoceptors
  British Journal of Pharmacology, 1985
• Myocardial β-adrenergic receptor downregulation in heart failure
  International Journal of Cardiology, 1984
• Drugs Five Years Later
  Annals of Internal Medicine, 1983
• Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: Reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors
  American Heart Journal, 1981